Targeting the androgen receptor in hormone-refractory prostate cancer – new concepts

By Eder Iris E   Haag Petra   Bartsch Georg   Klocker Helmut  

Future Oncology, Vol. 1, Iss. 1, 2005-02 ,pp. : 93-101

Future Medicine

Access to resources Recommend Favorite

The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 3, 2007-11 ,pp. : 203-211

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2⁺ patients with hormone-refractory prostate cancer

By Matsueda Satoko   Kobayashi Kazuhiko   Nonaka Yoichi   Noguchi Masanori   Itoh Kyogo   Harada Mamoru  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 479-489

Springer Publishing Company

Access to resources Recommend Favorite

Estramustine Phosphate Sodium: A Review of its Use in Combination Therapy for Hormone-Refractory Prostate Cancer

By Dene Simpson   Antona J. Wagstaff  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 373-390

Adis International

Access to resources Recommend Favorite

Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT)

By Cho D.   Di Blasio C.J.   Rhee A.C.   Kattan M.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 282-291

Elsevier

Access to resources Recommend Favorite